These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 12468049)
1. Can a healthy endothelium influence the cardiovascular effects of hormone replacement therapy? Koh KK Int J Cardiol; 2003 Jan; 87(1):1-8. PubMed ID: 12468049 [TBL] [Abstract][Full Text] [Related]
2. Effect of estrogen replacement therapy on endothelial function in peripheral resistance arteries in normotensive and hypertensive postmenopausal women. Higashi Y; Sanada M; Sasaki S; Nakagawa K; Goto C; Matsuura H; Ohama K; Chayama K; Oshima T Hypertension; 2001 Feb; 37(2 Pt 2):651-7. PubMed ID: 11230351 [TBL] [Abstract][Full Text] [Related]
3. Postmenopausal hormone replacement, risk estimators for coronary artery disease and cardiovascular protection. Mijatovic V; van der Mooren MJ; Stehouwer CD; Netelenbos JC; Kenemans P Gynecol Endocrinol; 1999 Apr; 13(2):130-44. PubMed ID: 10399059 [TBL] [Abstract][Full Text] [Related]
4. Postmenopausal hormone replacement therapy and cardiovascular disease. Chae CU; Ridker PM; Manson JE Thromb Haemost; 1997 Jul; 78(1):770-80. PubMed ID: 9198254 [TBL] [Abstract][Full Text] [Related]
6. Should progestins be blamed for the failure of hormone replacement therapy to reduce cardiovascular events in randomized controlled trials? Koh KK; Sakuma I Arterioscler Thromb Vasc Biol; 2004 Jul; 24(7):1171-9. PubMed ID: 15130916 [TBL] [Abstract][Full Text] [Related]
7. The effect of hormonal replacement therapy on the vascular reactivity and endothelial function of healthy individuals and individuals with type 2 diabetes. Lim SC; Caballero AE; Arora S; Smakowski P; Bashoff EM; Brown FM; Logerfo FW; Horton ES; Veves A J Clin Endocrinol Metab; 1999 Nov; 84(11):4159-64. PubMed ID: 10566666 [TBL] [Abstract][Full Text] [Related]
8. Short-term estrogen augments both nitric oxide-mediated and non-nitric oxide-mediated endothelium-dependent forearm vasodilation in postmenopausal women. Tagawa H; Shimokawa H; Tagawa T; Kuroiwa-Matsumoto M; Hirooka Y; Takeshita A J Cardiovasc Pharmacol; 1997 Oct; 30(4):481-8. PubMed ID: 9335408 [TBL] [Abstract][Full Text] [Related]
9. Sex hormone replacement therapy and modulation of vascular function in cardiovascular disease. Koledova VV; Khalil RA Expert Rev Cardiovasc Ther; 2007 Jul; 5(4):777-89. PubMed ID: 17605655 [TBL] [Abstract][Full Text] [Related]
11. A placebo-controlled trial of long-term oral combined continuous hormone replacement therapy in postmenopausal women: effects on arterial compliance and endothelial function. Teede HJ; Liang YL; Kotsopoulos D; Zoungas S; Cravent R; McGrath BP Clin Endocrinol (Oxf); 2001 Nov; 55(5):673-82. PubMed ID: 11894980 [TBL] [Abstract][Full Text] [Related]
12. Homocysteine in postmenopausal women and the importance of hormone replacement therapy. Mijatovic V; van der Mooren MJ Clin Chem Lab Med; 2001 Aug; 39(8):764-7. PubMed ID: 11592448 [TBL] [Abstract][Full Text] [Related]
14. Effect of hormone replacement therapy with the anti-mineralocorticoid progestin Drospirenone compared to tibolone on endothelial function and central haemodynamics in post-menopausal women. Vitale C; Mammi C; Gambacciani M; Russo N; Spoletini I; Fini M; Volterrani M; Rosano GMC Int J Cardiol; 2017 Jan; 227():217-221. PubMed ID: 27843051 [TBL] [Abstract][Full Text] [Related]
15. The effect of hormone replacement therapy on endothelial function in postmenopausal women with hypertension. Czarnecka D; Kawecka-Jaszcz K; Olszanecka A; Dembińska-Kieć A; Malczewska-Malec M; Zdzienicka A; Guevara I Med Sci Monit; 2004 Feb; 10(2):CR55-61. PubMed ID: 14737044 [TBL] [Abstract][Full Text] [Related]
16. Effect of lower dosage of oral conjugated equine estrogen on inflammatory markers and endothelial function in healthy postmenopausal women. Wakatsuki A; Ikenoue N; Shinohara K; Watanabe K; Fukaya T Arterioscler Thromb Vasc Biol; 2004 Mar; 24(3):571-6. PubMed ID: 14699021 [TBL] [Abstract][Full Text] [Related]
17. Postmenopausal hormone replacement therapy and the vascular wall: epidemiology and clinical studies. Joswig M; Hach-Wunderle V; von Holst T; Nawroth PP Vasa; 2000 Nov; 29(4):243-51. PubMed ID: 11141646 [TBL] [Abstract][Full Text] [Related]
18. Effect of hormone replacement therapy on plasma lipoproteins and apolipoproteins, endothelial function and myocardial perfusion in postmenopausal women with estrogen receptor-alpha IVS1-397 C/C genotype and established coronary artery disease. Emre A; Sahin S; Erzik C; Nurkalem Z; Oz D; Cirakoglu B; Yesilcimen K; Ersek B Cardiology; 2006; 106(1):44-50. PubMed ID: 16612068 [TBL] [Abstract][Full Text] [Related]
19. The impact of hormone replacement therapy on metabolic syndrome components in perimenopausal women. Korljan B; Bagatin J; Kokić S; Berović Matulić N; Barsić Ostojić S; Deković A Med Hypotheses; 2010 Jan; 74(1):162-3. PubMed ID: 19665311 [TBL] [Abstract][Full Text] [Related]
20. Hormone replacement therapy and coronary endothelial function in postmenopausal women. Singh A Mayo Clin Proc; 2005 Jun; 80(6):825; author reply 825-6. PubMed ID: 15945537 [No Abstract] [Full Text] [Related] [Next] [New Search]